NCT Number: NCT07822945
Assessment of knowledge of healthcare professionals of diabetes mellitus technology (continuous glucose monitoring systems and insulin pump therapy). The study is a cross-sectional, quantitative study at a tertiary university hospital in Thessaloniki, Greece
Interested in participating?
Request InfoAll sexes
Observational
Thessaloniki, 54636, Greece
Location status: Recruiting
Triantafyllos Didangelos, Professor of Internal Medicine
CONTACT
Triantafyllos Didangelos, Professor of Internal Medicine
PRINCIPAL_INVESTIGATOR
Zisis Kontoninas, MD, PhD
CONTACT
Zisis Kontoninas, MD,PhD
PRINCIPAL_INVESTIGATOR
Data will be collected using a standardized questionnaire. This questionnaire is based on a review of the relevant literature on diabetes management and related technologies. The final instrument consists of 37 closed-ended items. It was organized into four main sections, covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. Demographics will be also collected along with diabetes knowledge questions and 2 sections (1 for insulin pumps and 1 for continuous glucose monitoring).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A standardized questionnaire developed specifically based on a review of the relevant literature on diabetes management and related technologies
Time frame: Through study completion, an average of 1 year and 3 months
Questions on diabetes types, diagnostic criteria, risk factors for hypo- and hyperglycemia, symptom recognition, and glycemic targets.
Time frame: Through study completion, an average of 1 year and 3 months
The instrument was a questionnaire of 37 closed ended items organized in 4 sections covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. The questions for insulin use covered the knowledge of healthcare professionals on insulin regimens, dose calculation and administration, principles and benefits of insulin pump therapy, potential complications and appropriate actions in case of device malfunction.
Time frame: Through study completion, an average of 1 year and 3 months
Questions on system function, accuracy, indications for use, contribution to glycemic control, sensor placement and common issues during use.
Contact information is provided by the study sponsor or research team.
Triantafyllos Didangelos, Professor of Internal Medicine
CONTACT
Zisis Kontoninas, MD, PhD
CONTACT
Aristotle University Of Thessaloniki
Other
Healthcare Professionals' Knowledge of Continuous Glucose Monitoring and Insulin Pump Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07814508
Autoimmune Diseases, Continuous Glucose Monitoring System
Bad Mergentheim, Baden-Wurttemberg, Germany
View Trial DetailsNCT07184775
Continuous Glucose Monitoring System, Diabetes Mellitus
Sewell, New Jersey, United States
View Trial DetailsNCT07796802
Continuous Glucose Monitoring System, Diabetes
View Trial DetailsNCT07544368
Autoimmune Diseases, Continuous Glucose Monitoring System
View Trial Details